Nexgel (NXGLW) Cash & Equivalents (2019 - 2025)
Nexgel's Cash & Equivalents history spans 7 years, with the latest figure at $249000.0 for Q4 2025.
- For Q4 2025, Cash & Equivalents fell 86.22% year-over-year to $249000.0; the TTM value through Dec 2025 reached $249000.0, down 86.22%, while the annual FY2025 figure was $249000.0, 86.22% down from the prior year.
- Cash & Equivalents reached $249000.0 in Q4 2025 per NXGLW's latest filing, down from $938000.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $13.4 million in Q4 2021 to a low of $249000.0 in Q4 2025.
- Average Cash & Equivalents over 5 years is $2.7 million, with a median of $1.2 million recorded in 2021.
- Peak YoY movement for Cash & Equivalents: skyrocketed 41618.75% in 2021, then tumbled 92.52% in 2023.
- A 5-year view of Cash & Equivalents shows it stood at $13.4 million in 2021, then plummeted by 91.75% to $1.1 million in 2022, then skyrocketed by 145.23% to $2.7 million in 2023, then plummeted by 33.07% to $1.8 million in 2024, then tumbled by 86.22% to $249000.0 in 2025.
- Per Business Quant, the three most recent readings for NXGLW's Cash & Equivalents are $249000.0 (Q4 2025), $938000.0 (Q3 2025), and $725000.0 (Q2 2025).